Chromocell Therapeutics Corporation (CHRO)
USD 0.59
(-4.76%)
USD 0.59
(-4.76%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.28 USD | -193.02% |
| 2022 | -0.43 USD | -330.0% |
| 2021 | -0.10 USD | 9.09% |
| 2020 | -0.11 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.31 USD | 29.55% |
| 2024 Q1 | -0.44 USD | 36.23% |
| 2023 Q3 | -0.25 USD | -47.06% |
| 2023 Q1 | -0.17 USD | -30.77% |
| 2023 FY | - USD | -193.02% |
| 2023 Q2 | -0.17 USD | 0.0% |
| 2023 Q4 | -0.69 USD | -176.0% |
| 2022 Q4 | -0.13 USD | -34.72% |
| 2022 FY | - USD | -330.0% |
| 2022 Q3 | -0.10 USD | -66.67% |
| 2022 Q2 | -0.06 USD | -7.62% |
| 2022 Q1 | -0.05 USD | 0.0% |
| 2021 FY | - USD | 9.09% |
| 2020 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AIM ImmunoTech Inc. | -0.60 USD | -113.333% |
| Ampio Pharmaceuticals, Inc. | -10.67 USD | 88.004% |
| Armata Pharmaceuticals, Inc. | -1.91 USD | 32.984% |
| Actinium Pharmaceuticals, Inc. | -1.83 USD | 30.055% |
| Azitra, Inc. | -54.76 USD | 97.663% |
| Can-Fite BioPharma Ltd. | -1.79 USD | 28.492% |
| Calidi Biotherapeutics, Inc. | -1.73 USD | 26.012% |
| CEL-SCI Corporation | -0.73 USD | -75.342% |
| iBio, Inc. | -6.50 USD | 80.308% |
| Lineage Cell Therapeutics, Inc. | -0.12 USD | -966.667% |
| MAIA Biotechnology, Inc. | -1.49 USD | 14.094% |
| Matinas BioPharma Holdings, Inc. | -5.28 USD | 75.758% |
| Navidea Biopharmaceuticals, Inc. | -0.59 USD | -116.949% |
| NovaBay Pharmaceuticals, Inc. | -138.65 USD | 99.077% |
| NanoViricides, Inc. | -0.70 USD | -82.857% |
| Oragenics, Inc. | -9.18 USD | 86.057% |
| BiomX Inc. | -5.10 USD | 74.902% |
| BiomX Inc. | -5.10 USD | 74.902% |
| Protalix BioTherapeutics, Inc. | 0.12 USD | 1166.667% |
| Palatin Technologies, Inc. | -2.02 USD | 36.634% |
| Scorpius Holdings, Inc. | -347.20 USD | 99.631% |